CAMP FY 2014 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$251M+6.2% YoY

Gross Profit

$87M34.9% margin

Operating Income

$25M10.0% margin

Net Income

$17M6.6% margin

EPS (Diluted)

$0.45

Cash Flow

Operating Cash Flow

$29M

Free Cash Flow

$21M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$203M

Total Liabilities

$51M

Stockholders' Equity

$151M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$251M	$236M	+6.2%
Gross Profit	$87M	$80M	+9.3%
Operating Income	$25M	$18M	+36.0%
Net Income	$17M	$12M	+39.9%